LASMIDITAN, Lasmitidan, Lasmiditan, LASMIDITAN, Lasmiditan clinical trials

H8H-MC-LAHW: A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients with Migraine - PIONEER-PEDS2

This study, called PIONEER-PEDS2, is looking at a new medicine called Lasmiditan for children and teenagers with migraine headaches. It wants to see how safe the medicine is and if it causes any side effects over a year, specifically for each migraine attack treated.